ASPC 2018 Congress on CVD Prevention
Avatar

Charting New Territory – Inflammation as a CVD Target

By ASPC 2018 Congress on CVD Prevention FEATURING Christie Ballantyne
August 13, 2018
1 Comment
Login to view comments. Click here to Login

Featured Video

47:04
Lilly Diabetes

Discussion on Clinical Trial Results for Adults With Type 2 Diabetes

Feat. J. R. Gavin III, E. Miller

Featured Video

09:16
Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Metformin: What Does This GLP-1 RA Head-to-Head …

Feat. R. Pratley

Related Content

AUTOPLAY
16:57
William White

Ambulatory Blood Pressure Monitoring

27:18
Complex Coronary Valvular and Vascular Cases Conference

Can Coronary Artery Disease Be Eliminated In Our Lifetime?

20:40
Gerald S. Bloomfield

HIV: Heart Impacting Virus-How HIV and It’s Treatment Plague the Car…

23:44
Barbara Wiggins

The ART of Managing an HIV Patient’s Cardiovascular Disease: From Di…

07:24
Margaret Bowers

Primary Prevention of Cardiovascular Disease in an HIV Patient

23:04
Craig Beavers

HIV Heart-Attack: Optimizing Your HIV Patient Post Acute Coronary Sy…

25:28
ASPC 2018 Congress on CVD Prevention

What We Know and Don’t Know About Coronary Artery Calcium Imaging

Feat. K. Nasir
23:50
ASPC 2018 Congress on CVD Prevention

Keynote Address: Genetics in CVD Prevention: Insights and Opportunit…

Feat. S. Kathiresan
30:16
ASPC 2018 Congress on CVD Prevention

Session 1 Question and Answer Panel Discussion and Audience Response…

05:27
ASPC 2018 Congress on CVD Prevention

Gaining Access to PCSK9 Inhibitors: Dissemination of a Mobile App an…

Feat. M. Shapiro
16:50
Advances in Cardiovascular Disease Prevention

Paradigm Shifts: Understanding and Applying the Latest Lipid Guideli…

Feat. A. Freeman
14:23
Cardiology Fiesta 2018

The State of the Evidence in Severely Calcified Coronary Lesions

Feat. J. Hermiller
17:28
Northwestern Medicine: 6th Annual Cardiovascular Update

Paradigm Change in Lipid Treatment

Feat. N. Stone
13:02
Northwestern Medicine: 6th Annual Cardiovascular Update

Dyslipidemia: Who to Treat and When

Feat. N. Stone
22:24
Northwestern Medicine: 7th Annual Cardiovascular Update

Atherosclerotic Cardiovascular Disease: Should We Target LP(a), Infl…

Feat. J. Wilkins
34:46
Cardiovascular Disease Management: A Case-Based Approach 2018

PCI Post ORBITA: Does This Really Change Our Treatment of Chronic St…

Feat. K. Garratt
19:18
The 8th Annual International Hawaii Symposium on Diagnostic and Therapeutic Modalities in Heart Failure

Cardiovascular Disease in Women: Update 2018

Feat. N. Merz
15:54
The American Society for Preventive Cardiology

Assessment and Management of Severe Hypercholesterolemia

Feat. A. Khera
06:51
Amit Khera

ASPC Update on the New 2018 Cholesterol Guidelines Discussion

27:19
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Lowering LDL and Reducing CV Events with PCSK9 Inhibitors

Feat. P. Taub